Here’s a few examples of my recent work. Click on the titles to link to the articles. If you cannot access them I’m happy to send you a pdf. I also write web-only content for Frontline Genomics and Drug Hunter.

Shared science’s time to shine
Sharing research tools and data with other scientists brings many benefits, such as using fewer animals, improving reproducibility and increasing study sample size, but the practice still needs to be more widely adopted.
Lab Animal

Monkeypox response relies on three vaccine suppliers
Biodefense stockpiles are helping to curb the monkeypox outbreak, but the vaccines are based on old technology with significant side effects. Are other vaccines on the horizon?
Nature Biotechnology

Mice on the move
Animal welfare concerns, reduced flight options and increased costs are pushing researchers to consider shipping frozen sperm and embryos rather than live mice.
Lab Animal

COVID-19 feature articles in Nature Biotechnology
Focus shifts to antibody cocktails for COVID-19 cytokine storm
Drug researchers pursue new lines of attack against COVID-19
Coronavirus puts drug repurposing on the fast track
Featured on ‘In the Pipeline’ blog and Nature News daily briefing; used by PR Newswire.

Green funds for lab-made breast milk
Nature Biotechnology

First CRISPR therapy dosed
Nature Biotechnology

FDA dictates on gene therapy sameness
Nature Biotechnology

Digital drug fortunes falter
Nature Biotechnology

First Ebola vaccine approved
Nature Biotechnology

TB vaccine upswing for GSK
Nature Biotechnology

First gene therapy for β-thalassemia approved
Bluebird Bio’s gene therapy eliminates the need for blood transfusions in patients with β-thalassemia
Nature Biotechnology

Hot topics: CRISPR therapies are moving toward clinical development
The Bracken Group

Clinical trial data transparency: helping patients and physicians find results
The Bracken Group

Three economic trends facing the pharma and biotech industry
The Bracken Group